How Is AI Impacting Pharma and Biotech?

Posted June 4, 2019 in Data Analytics & Digital Technologies
Pharma and Biotech

Identifying and developing new drugs and conducting clinical trials involve complex and lengthy (i.e., costly) processes that require researchers and drug manufacturers to integrate, manage, and analyze incredible amounts of data while at the same time collaborate with other medical research and pharma companies in their efforts. Pharmaceutical and biotechnology companies are using artificial intelligence (AI) to optimize the discovery and evaluation of new drug compounds, to explore patient and efficacy data, and to develop and bring new therapies to market.

About The Author
Curt Hall
Curt Hall is a Senior Consultant with Cutter Consortium’s Data Analytics & Digital Technologies and Business & Enterprise Architecture practices. He has extensive experience as an IT analyst covering technology trends, application development trends, markets, software, and services. Mr. Hall's expertise includes artificial intelligence (AI), cognitive systems, machine learning, conversational computing, and advanced analytics. He also… Read More
Not a member? Gain Access to the Cutter Experts today — register now to read select open-access articles.